Juliet Nakamya Selected Research

Juliet Nakamya Research Topics

6	Atrial Fibrillation 01/2021 - 02/2013
5	Hemorrhage 01/2021 - 02/2013
4	Stroke (Strokes) 07/2018 - 02/2013
2	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2021 - 01/2019
2	Embolism (Embolus) 01/2021 - 02/2013
1	Ischemic Stroke 01/2021
1	Heart Failure 01/2021
1	ST Elevation Myocardial Infarction 10/2019
1	Myocardial Infarction 10/2019
1	Hypertension (High Blood Pressure) 05/2014

3	Factor Xa (Coagulation Factor Xa)IBA 01/2021 - 01/2016
3	PRT064445IBA 01/2021 - 01/2016
2	Hemostatics (Antihemorrhagics)IBA 01/2021 - 01/2019
2	A-factor (Streptomyces)IBA 01/2019 - 01/2016
2	Enoxaparin (Lovenox)FDA LinkGeneric 01/2019 - 01/2016
2	Factor Xa InhibitorsIBA 01/2019 - 01/2016
2	AnticoagulantsIBA 07/2018 - 01/2017
2	Warfarin (Coumadin)FDA LinkGeneric 01/2017 - 02/2013
2	Dabigatran FDA Link 01/2017 - 02/2013
1	AntidotesIBA 01/2021
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 02/2013

4	Therapeutics 01/2021 - 02/2013
1	Patient Readmission 01/2021
1	Percutaneous Coronary Intervention 10/2019
1	Defibrillators (Defibrillator) 05/2014